Empower India Limited has submitted its quarterly compliance certificate to BSE Limited for the quarter ended March 31, 2026, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The filing, dated April 13, 2026, was signed by Director Satyawan Jankar and addresses mandatory compliance obligations for listed companies.

Regulatory Compliance Details

The certificate pertains to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, which requires companies to report on dematerialization activities. The document confirms that no physical share certificates were received for dematerialization of equity shares during the reporting period.

Registrar and Transfer Agent Confirmation

Skyline Financial Services Private Limited, serving as the company's registrar and share transfer agent, issued the confirmation certificate on April 02, 2026. The certificate was signed by Parveen Sharma, Authorised Signatory, confirming compliance with the regulatory requirements for the quarter.

Corporate Information

Empower India Limited operates under CIN L51900MH1981PLC023931 with its registered office located at 25/25A, 2nd Floor, 327, Nawab Building, D. N. Road, Fort, Mumbai. The company maintains its listing on BSE Limited under scrip code 504351.

Depositories Notification

As part of the compliance process, the certificate has been shared with both major depositories in India - National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL). This ensures comprehensive regulatory compliance across the securities market infrastructure.

Empower India Limited has announced a significant leadership change with the resignation of its Managing Director and Chief Financial Officer, Mr. Rajgopalan Iyengar, effective from April 08, 2026. The development was disclosed through a regulatory filing under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Board Meeting Outcome

The company's Board of Directors convened on April 09, 2026, from 04:30 PM to 05:00 PM at the registered office to formally address and approve Mr. Iyengar's resignation. The meeting was held in compliance with regulatory requirements to ensure proper disclosure of material changes in key management personnel.

Resignation Details

Mr. Rajgopalan Iyengar (DIN: 00016496) submitted his resignation letter on April 08, 2026, citing medical reasons that require his immediate and complete attention. In his resignation letter, he expressed that this was a difficult decision made with deep responsibility toward his health and well-being.

Regulatory Compliance

The company has fulfilled all disclosure requirements under SEBI regulations, providing comprehensive details as mandated. The filing was made pursuant to Regulation 30 read with Schedule III of the SEBI Listing Regulations and SEBI Master Circular dated January 30, 2026. Key compliance aspects include:

• Submission of detailed resignation letter with reasons
• Confirmation of no other material reasons beyond medical grounds
• Declaration of no directorships in other listed entities
• Proper board resolution and approval process

Leadership Transition

Mr. Iyengar acknowledged the inconvenience his sudden departure may cause to the organization while expressing gratitude for the trust and support extended during his tenure. He described his service as an honor and highlighted his contribution to the organization's growth and success.

The resignation letter confirms that there are no other reasons beyond the medical circumstances mentioned, providing clarity on the nature of his departure. The company has not yet announced interim arrangements or succession plans for the dual role of Managing Director and Chief Financial Officer. Director Satyawan Jankar (DIN: 10711274) signed the regulatory filing on behalf of the company.